Research guide on TRIPS and compulsory licensing:access to innovative pharmaceuticals for least developed countries
Online guide focusing on the legal and economic factors preventing poorer countries gaining access to innovative drugs, by patent attorney Do Hyung Kim. Pubished on New York University's Globalex website and updated periodically, it gives background information about the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and looks at the problems of compulsory licensing, such as the risks of arbitrage and counterfeit drugs.